DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
271	強直性脊椎炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00235105 (ClinicalTrials.gov)	March 2005	6/10/2005	D2E7-Early AS	Adalimumab in Early Axial Spondyloarthritis (Without Radiological Sacroiliitis): Placebo Controlled Phase Over 3 Months Followed by a 9 Months Open Extension Phase	Ankylosing Spondylitis	Drug: Adalimumab 40 mg sc every other week	Charite University, Berlin, Germany	Abbott	Active, not recruiting	18 Years	N/A	Both	46	Phase 2;Phase 3	Germany

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00235105
(ClinicalTrials.gov)

March 2005

6/10/2005

D2E7-Early AS

Adalimumab in Early Axial Spondyloarthritis (Without Radiological Sacroiliitis): Placebo Controlled Phase Over 3 Months Followed by a 9 Months Open Extension Phase

Ankylosing Spondylitis

Drug: Adalimumab 40 mg sc every other week

Charite University, Berlin, Germany

Abbott

Active, not recruiting

18 Years

N/A

Both

Phase 2;Phase 3

Germany